SciSparc Ltd. (SPRC)
NASDAQ: SPRC · Real-Time Price · USD
8.55
-0.76 (-8.16%)
At close: Jun 12, 2026, 4:00 PM EDT
8.80
+0.25 (2.92%)
After-hours: Jun 12, 2026, 7:14 PM EDT
SciSparc Revenue
In the year 2025, SciSparc had annual revenue of $856.00K, down -34.46%. SciSparc had revenue of $856.00K in the quarter ending December 31, 2025, a decrease of -34.46%.
Revenue (ttm)
$856.00K
Revenue Growth
-34.46%
P/S Ratio
5.73
Revenue / Employee
$285,333
Employees
3
Market Cap
4.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 856.00K | -450.00K | -34.46% |
| Dec 31, 2024 | 1.31M | -1.57M | -54.64% |
| Dec 31, 2023 | 2.88M | 1.53M | 113.73% |
| Dec 31, 2022 | 1.35M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bio Green Med Solution | 1.53M |
| XTL Biopharmaceuticals | 968.00K |
| CollPlant Biotechnologies | 389.00K |
| Pulmatrix | 3.00K |
| Alaunos Therapeutics | 3.00K |
| Soligenix | 2.34K |
SPRC News
- 9 days ago - SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum - GlobeNewsWire
- 9 days ago - Neurothera Labs Inc. Announces Closing Of Acquisition Of Majority Stake In Cliniquantum Ltd. - TheNewswire
- 16 days ago - SciSparc: Subsidiary NeuroThera Labs Received Conditional Regulatory Approval for Acquisition of CliniQuantum - GlobeNewsWire
- 23 days ago - Neurothera Labs Announces Adoption of Semi-Annual Reporting - TheNewswire
- 6 weeks ago - Neurothera Labs Announces Continuance into Ontario - TheNewswire
- 7 weeks ago - Neurothera Labs Engages bullVestor for Investor Relations Activities - TheNewswire
- 3 months ago - SciSparc discloses patent application for depression yherapy - TheFly
- 3 months ago - SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy - GlobeNewsWire